​

Korro Bio (KRRO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

KRRO Stock Forecast

Korro Bio (KRRO) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $91.25, with a high of $120.00 and a low of $25.00. This represents a 127.67% increase from the last price of $40.08.

$25 $44 $63 $82 $101 $120 High: $120 Avg: $91.25 Low: $25 Last Closed Price: $40.08

KRRO Stock Rating

Korro Bio stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 1 Strong Buy (12.50%), 7 Buy (87.50%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 7 1 Strong Sell Sell Hold Buy Strong Buy

KRRO Price Target Upside V Benchmarks

TypeNameUpside
StockKorro Bio127.67%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$25.00
Last Closing Price$40.08$40.08$40.08
Upside/Downside---37.62%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2536---9
Sep, 2537---10
Aug, 2546---10
Jul, 2546---10
Jun, 2546---10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 16, 2025Keay NakaeChardan Capital$25.00$13.4685.74%-37.62%
Oct 21, 2024Luca IssiRBC Capital$105.00$76.9436.47%161.98%
May 15, 2024Kostas BiliourisBMO Capital$120.00$50.05139.76%199.40%
Mar 28, 2024H.C. Wainwright$115.00$88.5329.90%186.93%
Mar 27, 2024RBC Capital$90.00$89.830.19%124.55%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 28, 2025Cantor FitzgeraldOverweightinitialise
Jan 10, 2025OppenheimerOutperforminitialise
Oct 21, 2024Raymond JamesStrong Buyinitialise
Oct 21, 2024RBC CapitalOutperformOutperformhold
Oct 18, 2024H.C. WainwrightBuyBuyhold
Oct 16, 2024BMO CapitalOutperformOutperformhold
Sep 17, 2024BMO CapitalOutperformOutperformhold
Sep 17, 2024H.C. WainwrightBuyBuyhold
Aug 15, 2024BMO CapitalOutperformOutperformhold
Aug 14, 2024Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-85 $-68 $-51 $-34 $-17 $0 Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-41.10$-4.94$-53.09$-9.37----
Avg Forecast$-39.02$-84.26$-12.68$-9.25$-9.74$-9.10$-10.31$-10.73
High Forecast$-39.02$-84.26$-12.45$-8.83$-7.92$-6.74$-7.47$-10.73
Low Forecast$-39.02$-84.26$-12.90$-9.52$-11.06$-11.62$-12.32$-10.73
Surprise %5.33%-94.14%318.69%1.30%----

Revenue Forecast

$5M $14M $23M $32M $41M $50M Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$36.98M$14.07M-$2.27M----
Avg Forecast$35.39M$45.07M-----$9.38M
High Forecast$35.39M$45.07M-----$9.38M
Low Forecast$35.39M$45.07M-----$9.38M
Surprise %4.50%-68.79%------

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-26.51M$-21.96M$-81.17M$-83.58M----
Avg Forecast$-59.68M$-128.87M$-19.38M$-14.03M$-14.51M$-14.04M$-15.13M$-16.41M
High Forecast$-59.68M$-128.87M$-19.04M$-13.51M$-12.11M$-10.30M$-11.42M$-16.41M
Low Forecast$-59.68M$-128.87M$-19.73M$-14.56M$-16.91M$-17.77M$-18.84M$-16.41M
Surprise %-55.58%-82.96%318.75%495.61%----

KRRO Forecast FAQ

Is Korro Bio stock a buy?

Korro Bio stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 7 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Korro Bio is a favorable investment for most analysts.

What is Korro Bio's price target?

Korro Bio's price target, set by 8 Wall Street analysts, averages $91.25 over the next 12 months. The price target range spans from $25 at the low end to $120 at the high end, suggesting a potential 127.67% change from the previous closing price of $40.08.

How does Korro Bio stock forecast compare to its benchmarks?

Korro Bio's stock forecast shows a 127.67% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Korro Bio over the past three months?

  • October 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 30.00% Strong Buy, 70.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Korro Bio’s EPS forecast?

Korro Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-9.74, marking a 3.95% increase from the reported $-9.37 in 2024. Estimates for the following years are $-9.1 in 2026, $-10.31 in 2027, and $-10.73 in 2028.

What is Korro Bio’s revenue forecast?

Korro Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a -100.00% decrease from the reported $2.27M in 2024. The forecast for 2026 is $0, followed by $0 for 2027, and $9.38M for 2028.

What is Korro Bio’s net income forecast?

Korro Bio's net income forecast for the fiscal year ending in December 2025 stands at $-14.509M, representing a -82.64% decrease from the reported $-83.581M in 2024. Projections indicate $-14.037M in 2026, $-15.13M in 2027, and $-16.407M in 2028.